Importantly, pharmacological inhibition of the TGFβ pathway improves the DNA repair capacities of FA cells by inhibiting the expression of NHEJ genes and increasing the expression of homologous recombination (HR) genes [10]. The gene discussed is TGFB1; the disease is Friedreich ataxia.